Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer.

Pietri, Elisabetta

Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer. [electronic resource] - The oncologist 06 2019 - 743-e205 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1549-490X

10.1634/theoncologist.2018-0243 doi


Administration, Oral
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Aromatase Inhibitors--administration & dosage
Breast Neoplasms--drug therapy
Dehydroepiandrosterone--administration & dosage
Disease Progression
Drug-Related Side Effects and Adverse Reactions--epidemiology
Female
Humans
Middle Aged
Prospective Studies
Receptors, Androgen--metabolism
Receptors, Estrogen--metabolism
Response Evaluation Criteria in Solid Tumors
Survival Analysis
Time Factors
Triple Negative Breast Neoplasms--drug therapy